ArticleAmerican journal of translational research2026
Flexible ureterorenoscopy with holmium laser lithotripsy for ureteral calculi complicated by hydronephrosis.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo clarify the effects of flexible ureterorenoscopy (FURS) combined with holmium laser lithotripsy on surgical outcomes, postoperative pain (POP), and renal function (RF) for the treatment of ureteral calculi (UC) complicated by hydronephrosis (HN).
methodsA total of 128 patients diagnosed with UC complicated with HN treated between February 2024 and December 2025 were enrolled in this retrospective study and divided according to surgical approach. Among them, 65 patients underwent FURS combined with holmium laser lithotripsy (FURS group), and 63 patients received conventional ureteroscopy (URS) combined with laser lithotripsy (URS group). The two groups were compared in terms of clinical efficacy, surgical metrics (intraoperative blood loss, operative time, one-time stone clearance success rate), hospitalization indicators (hospitalization duration and medical expenses), POP, renal function, routine urine test results, serum inflammatory markers, and postoperative complications.
resultsThe FURS group exhibited a significantly higher overall treatment efficacy rate (P=0.035). Additionally, the FURS group had less intraoperative blood loss, a shorter operative time, and a shorter hospital stay (all P<0.001). In terms of postoperative recovery, patients in the FURS group experienced milder pain on postoperative days 1 (P=0.032) and 3 (P<0.001), with better preserved postoperative renal function (P<0.05), improved routine urine test indicators (P<0.05), lower serum inflammatory levels (P<0.05), and fewer total complications (P<0.001). No significant differences were observed between the two groups in the one-time stone clearance success rate and hospitalization expenses (all P>0.05).
conclusionFURS demonstrated significantly superior clinical efficacy to conventional URS for the treatment of UC complicated by HN, with better surgical outcome and more safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.